News | Thrombectomy Devices | January 30, 2025

Penumbra Launches Laser-Cut Hypotube Sheath Designed for Venous Thromboembolism

The Element Vascular Access System, the first laser-cut hypotube sheath is designed for venous thromboembolism and is compatible with Lightning Flash 2.0. 


Penumbra recently launched its Element Vascular Access System, a laser-cut hypotube sheath designed for venous thromboembolism (VTE). The Element Vascular Access System is compatible with Lightning Flash 2.0, a powerful and advanced mechanical thrombectomy system for the removal of venous thrombus and the treatment of pulmonary embolism (PE), effectively completing Penumbra’s VTE platform.

“The flexibility and torqueability of the Lightning Flash 2.0 catheter paired with the foundational support of the Element sheath has allowed us excellent angiographic and clinical success,” said Raj Kakarla, M.D., interventional radiologist at Javon Bea Hospital in Rockford, Illinois. “Penumbra’s continuous advancements provide a comprehensive portfolio for physicians to treat a wider range of patients and improve patient outcomes.”

Innovative Valve Technology 

Element features the HemoLock Valve System, designed to ensure hemostasis through dual-valve engineering. Equipped with a rotating hemostatic valve and a removable cross-cut valve, the system provides physicians with precise control during procedures.

Advanced Hypotube Engineering 

The Element laser-cut hypotube design is engineered to maintain stepwise support throughout vasculature to enhance performance across challenging anatomies. The atraumatic tip design is meticulously crafted to help enable smooth delivery and trackability. The proximal segment is purposefully engineered to deliver foundational support, while optimized polymer transitions help maintain sheath access without the application of proximal hydrophilic coatings.

The Element hypotube is composed of 17 French MaxID technology, tailor-made for use in conjunction with the Lightning Flash 2.0, CATTM16 catheter. This technology enables in-case visualization via hand injection around the CAT16 and provides sufficient space to torque CAT16.

Additional information about Penumbra’s products is available at hwww.penumbrainc.com/providers.  


Additional Content

News | Thrombectomy Devices

Oct.19, 2026 – Jupiter Endovascular has announced publication of full results from its SPIRARE II pivotal trial ...

Home October 20, 2026
Home
News | Thrombectomy Devices

Oct. 12, 2026 — Endovascular Engineering (E2) has announced that the U.S. Food and Drug Administration (FDA) has granted ...

Home October 13, 2026
Home
News | Thrombectomy Devices

Sept. 8, 2026 — Penumbra recently launched the Link clot capture device designed to support the removal of arterial ...

Home September 15, 2026
Home
News | Thrombectomy Devices

Aug. 29, 2026— Vesalio recently announced results from the NATURE trial (NCT04969471), a prospective, randomized ...

Home September 10, 2026
Home
News | Thrombectomy Devices

July 21, 2026 — Vesalio recently announced that the results from the randomized NATURE clinical trial evaluating the ...

Home July 21, 2026
Home
Subscribe Now